COVID-19 pandemic in Yemen: A questionnaire based survey, what do we know?

被引:8
|
作者
Dhabaan, Ghulam [1 ]
Chahin, Abdullah [2 ,3 ,4 ]
Buhaish, Abdulrahman
Shorman, Mahmoud [5 ]
机构
[1] Univ Toronto, Mt Sinai Hosp, Dept Microbiol, Univ Hlth Network, Toronto, ON, Canada
[2] Brown Univ, Div Infect Dis, Kent Cty Mem Hosp, Providence, RI USA
[3] Brown Univ, Crit Care Div, Kent Cty Mem Hosp, Providence, RI USA
[4] Brown Univ, Alpert Med Sch, Providence, RI USA
[5] Univ Tennessee, Div Infect Dis, Med Ctr, Knoxville, TN 37920 USA
来源
关键词
COVID-19; Yemen; Coronavirus; Covid-19; pandemic; CLINICAL CHARACTERISTICS;
D O I
10.3855/jidc.13966
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Coronavirus infectious disease 2019 (COVID-19) is currently one of the most important public health crises affecting the global human population. It continues to spread widely, as the world still lacks specific treatments and a vaccine for the virus. The scenario of COVID-19 in Yemen seems obscure due to the lack of adequate data, therefore, we developed an electronic questionnaire and distributed it online among Yemeni people. The aim of this study was to understand the COVID-19 epidemiological situation in Yemen better since there is currently limited published data and limited availability of COVID-19 testing. Methodology: A 34-question web-based survey was distributed on social media outlets targeting people in Yemen. Data aggregation, analysis, and visualization were performed using Tableau and Microsoft Excel. Results: 2,341 individuals reported symptoms concerning for COVID-19 infection, with 25.4% reporting a chronic medical condition. Diabetes, hypertension, asthma, and immune deficiency were associated with increased severity of the disease, while obesity, cardiovascular disease, kidney disease, and liver disease were not. Only 37 individuals (1.6%) had a confirmatory COVID-19 PCR test. The presence of high fever, dyspnea, chest pain, and dysphagia were symptoms that tended to be correlated to worse clinical outcomes. Conclusions: This study provides some important information about the early overspread of COVID-19 within the Yemeni community in May, June, and July of 2020. It shows that online questionnaires may help in collecting data about pandemics in resource-limited countries where testing availability is limited.
引用
收藏
页码:1374 / 1379
页数:6
相关论文
共 50 条
  • [31] Liver injury in COVID-19: What do we know now?
    Hua-Yu Yang
    Bao Jin
    Yi-Lei Mao
    Hepatobiliary & Pancreatic Diseases International, 2020, 19 (05) : 407 - 408
  • [32] Covid-19 and dizziness: what do we know so far?
    Mezzalira, Raquel
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2022, 88 (03) : 287 - 288
  • [33] Immune response in COVID-19: What do we currently know?
    Oliveira, Daniela S.
    Medeiros, Nayara I.
    Gomes, Juliana A. S.
    MICROBIAL PATHOGENESIS, 2020, 148
  • [34] COVID-19 and Hematology—What Do We Know So Far?
    Harshwardhan Khandait
    Garima Gandotra
    Sonali Sachdeva
    Courtney A. Kramer
    Derek Nye
    Reshma Golamari
    Rohit Jain
    SN Comprehensive Clinical Medicine, 2020, 2 (12) : 2631 - 2636
  • [35] Bereavement during the Covid-19 pandemic n the UK: What do we know so far?
    Harrop, Emily
    Selman, Lucy E.
    BEREAVEMENT-JOURNAL OF GRIEF AND RESPONSES TO DEATH, 2022, 1
  • [36] Covid-19: What do we know about omicron sublineages?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 376
  • [37] COVID-19 and the liver: What do we know so far?
    Prashant Nasa
    George Alexander
    World Journal of Hepatology, 2021, 13 (05) : 522 - 532
  • [38] Elective procedures in times of COVID-19: ?What do we know?
    Ensuncho, Cesar
    ARCHIVOS DE MEDICINA, 2020, 20 (02): : 513 - 517
  • [39] COVID-19 and diabetes: What do we know so far?
    Gangadaran, Prakash
    Padinjarathil, Himabindu
    Rajendran, Shri Hari Subhashri
    Jogalekar, Manasi P.
    Hong, Chae Moon
    Aruchamy, Baladhandapani
    Rajendran, Uma Maheswari
    Gurunagarajan, Sridharan
    Krishnan, Anand
    Ramani, Prasanna
    Subramanian, Kavimani
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (15) : 1330 - 1334
  • [40] COVID-19 and the liver: What do we know so far?
    Nasa, Prashant
    Alexander, George
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (05) : 522 - 532